Global Insulin delivery system Market By Product (Insulin Pen, Insulin Pump, Insulin Syringe, Others) By Distribution Channel (Hospitals, Diabetes Specialty Clinics, Retail Channels), By Region And Key Companies - Industry Segment Outlook, Market Assessment, Competition Scenario, Trends And Forecast 2020-2027

• 1.1 Preface
• 1.2 Assumptions
• 1.3 Abbreviations

2.0 Chapter 2

• 2.1 Report Description
  • 2.1.1 Market Definition and Scope
  • 2.1.2 Opportunity Map Analysis
• 2.2 Executive Summary
  • 2.2.1 Market Snapshot, By Product
  • 2.2.2 Market Snapshot, By Distribution Channel
  • 2.2.3 Market Snapshot, By Region

3.0 Chapter 3

• 3.0.1 Global Insulin Delivery Systems Market Dynamics
• 3.0.2 Drivers
• 3.0.3 Restrains
• 3.0.4 Opportunities
• 3.0.5 Trends
• 3.0.6 DR Impact Analysis
• 3.0.7 PEST Analysis
• 3.0.8 Porter’s Five Forces Analysis
• 3.0.9 Percentage of Deaths Attributed to High Blood Glucose at Ages 20–69 Years
• 3.0.10 High Blood Glucose Age-Standardized Mortality Rates
• 3.0.11 Estimated Prevalence and Number of People with Diabetes (2014)
• 3.0.12 Worldwide Prevalence of Diabetes, 2012–2016

4.0 Chapter 4

• 4.0.1 Global Insulin Delivery Systems Market Analysis, by Product
• 4.0.2 Overview
• 4.0.3 Segment Trends
• 4.0.4 Market Share and Forecast, and Y-o-Y Growth, 2016–2026, (US$ Mn)
• 4.1 Insulin Pen
  • 4.1.1 Overview
  • 4.1.2 Market Share and Forecast, and Y-o-Y Growth, 2016-2026, (US$ Mn)
• 4.2 Insulin Pump
  • 4.2.1 Overview
  • 4.2.2 Market Share and Forecast, and Y-o-Y Growth, 2016-2026, (US$ Mn)
  • 4.2.3 Insulin Pump Hardware Schematic
  • 4.2.4 Activity Model of the Insulin Pump
• 4.3 Insulin Syringe
  • 4.3.1 Overview
  • 4.3.2 Market Share and Forecast, and Y-o-Y Growth, 2016-2026, (US$ Mn)
• 4.4 Others
  • 4.4.1 Overview
  • 4.4.2 Market Share and Forecast, and Y-o-Y Growth, 2016-2026, (US$ Mn)

5.0 Chapter 5

• 5.0.1 Global Insulin Delivery Systems Market Analysis, by Distribution Channel
• 5.0.2 Overview
• 5.0.3 Segment Trends
• 5.0.4 Market Share and Forecast, and Y-o-Y Growth, 2016-2026, (US$ Mn)
• 5.1 Hospitals
  • 5.1.1 Overview
  • 5.1.2 Market Share and Forecast, and Y-o-Y Growth, 2016-2026, (US$ Mn)
• 5.2 Diabetes Specialty Clinics
  • 5.2.1 Overview
  • 5.2.2 Market Share and Forecast, and Y-o-Y Growth, 2016-2026, (US$ Mn)
• 5.3 Retail Channels
  • 5.3.1 Overview
  • 5.3.2 Market Share and Forecast, and Y-o-Y Growth, 2016-2026, (US$ Mn)

6.0 Chapter 6

• 6.0.1 Global Insulin Delivery Systems Market Analysis, by Region
• 6.0.2 Market Attractiveness Index
• 6.0.3 Overview
• 6.0.4 Regional Trends
• 6.0.5 Market Share and Forecast, and Y-o-Y Growth, 2016-2026, (US$ Mn)
• 6.1 North America
  • 6.1.1 Overview
  • 6.1.2 Country Trends
  • 6.1.3 Market Share and Forecast, and Y-o-Y Growth, 2016–2026, (US$ Mn)
  • 6.1.4 US
    • 6.1.4.1 Market Value and Forecast, 2016–2026, (US$ Mn)
  • 6.1.5 Canada
    • 6.1.5.1 Market Value and Forecast, 2016–2026, (US$ Mn)
  • 6.1.6 US Diabetes Forecasts–2015 to 2030
  • 6.1.7 Prevalence of Diabetes in 2017, By Country
• 6.2 Europe
  • 6.2.1 Overview
  • 6.2.2 Country Trends
  • 6.2.3 Market Share and Forecast, and Y-o-Y Growth, 2016-2026, (US$ Mn)
  • 6.2.4 Germany
    • 6.2.4.1 Market Value and Forecast, 2016–2026, (US$ Mn)
  • 6.2.5 France
    • 6.2.5.1 Market Value and Forecast, 2016–2026, (US$ Mn)
  • 6.2.6 UK
    • 6.2.6.1 Market Value and Forecast, 2016–2026, (US$ Mn)
  • 6.2.7 Russia
    • 6.2.7.1 Market Value and Forecast, 2016–2026, (US$ Mn)
  • 6.2.8 Italy
    • 6.2.8.1 Market Value and Forecast, 2016–2026, (US$ Mn)
  • 6.2.9 Prevalence of Diabetes in 2017, By Country
• 6.3 Asia Pacific
  • 6.3.1 Overview
  • 6.3.2 Country Trends
  • 6.3.3 Market Share and Forecast, and Y-o-Y Growth, 2016–2026, (US$ Mn)
  • 6.3.4 China
    • 6.3.4.1 Market Value and Forecast, 2016–2026, (US$ Mn)
  • 6.3.5 Japan
    • 6.3.5.1 Market Value and Forecast, 2016–2026, (US$ Mn)
  • 6.3.6 South Korea
    • 6.3.6.1 Market Value and Forecast, 2016–2026, (US$ Mn)
  • 6.3.7 India
    • 6.3.7.1 Market Value and Forecast, 2016–2026, (US$ Mn)
  • 6.3.8 Southeast Asia
    • 6.3.8.1 Market Value and Forecast, 2016–2026, (US$ Mn)
  • 6.3.9 Prevalence of Diabetes in 2017, By Country
• 6.4 Latin America
  • 6.4.1 Overview
  • 6.4.2 Country Trends
  • 6.4.3 Market Share and Forecast, and Y-o-Y Growth, 2016–2026, (US$ Mn)
  • 6.4.4 Brazil
    • 6.4.4.1 Market Value and Forecast, 2016–2026, (US$ Mn)
  • 6.4.5 Mexico
    • 6.4.5.1 Market Value and Forecast, 2016–2026, (US$ Mn)
  • 6.4.6 Rest of Latin America
    • 6.4.6.1 Market Value and Forecast, 2016–2026, (US$ Mn)
  • 6.4.7 Prevalence of Diabetes in 2017, By Country
• 6.5 Middle East & Africa
  • 6.5.1 Overview
  • 6.5.2 Country Trends
  • 6.5.3 Market Share and Forecast, and Y-o-Y Growth, 2016–2026, (US$ Mn)
  • 6.5.4 GCC
    • 6.5.4.1 Market Value and Forecast, 2016–2026, (US$ Mn)
  • 6.5.5 Israel
    • 6.5.5.1 Market Value and Forecast, 2016–2026, (US$ Mn)
  • 6.5.6 South Africa
    • 6.5.6.1 Market Value and Forecast, 2016–2026, (US$ Mn)
  • 6.5.7 Rest of Middle East & Africa
    • 6.5.7.1 Market Value and Forecast, 2016–2026, (US$ Mn)
  • 6.5.8 Prevalence of Diabetes in 2017, By Country

7.0 Chapter 7

• 7.0.1 Company Profiles
• 7.0.1 Heat Map Analysis
• 7.1 Becton, Dickinson and Company
  • 7.1.1 Company Overview
  • 7.1.2 Product Portfolio
  • 7.1.3 Financial Overview
  • 7.1.4 Key Developments
  • 7.1.5 SWOT Analysis
• 7.2 Eli Lilly and Company
  • 7.2.1 Company Overview
  • 7.2.2 Product Portfolio
  • 7.2.3 Financial Overview
  • 7.2.4 Key Developments
  • 7.2.5 SWOT Analysis
• 7.3 Medtronic plc
  • 7.3.1 Company Overview
  • 7.3.2 Product Portfolio
  • 7.3.3 Financial Overview
  • 7.3.4 Key Developments
  • 7.3.5 SWOT Analysis
• 7.4 Sanofi
  • 7.4.1 Company Overview
  • 7.4.2 Product Portfolio
  • 7.4.3 Financial Overview
  • 7.4.4 Key Developments
  • 7.4.5 SWOT Analysis
• 7.5 F. Hoffmann-La Roche Ltd.
  • 7.5.1 Company Overview
  • 7.5.2 Product Portfolio
  • 7.5.3 Financial Overview
  • 7.5.4 Key Developments
  • 7.5.5 SWOT Analysis
• 7.6 Cellnovo Limited
  • 7.6.1 Company Overview
  • 7.6.2 Product Portfolio
  • 7.6.3 Financial Overview
  • 7.6.4 Key Developments
  • 7.6.5 SWOT Analysis
• 7.7 Insulet Corporation
  • 7.7.1 Company Overview
  • 7.7.2 Product Portfolio
  • 7.7.3 Financial Overview
  • 7.7.4 Key Developments
  • 7.7.5 SWOT Analysis
• 7.8 Tandem Diabetes Care, Inc.
  • 7.8.1 Company Overview
  • 7.8.2 Product Portfolio
  • 7.8.3 Financial Overview
  • 7.8.4 Key Developments
  • 7.8.5 SWOT Analysis
• 7.9 Companion Medical, Inc.
  • 7.9.1 Company Overview
  • 7.9.2 Product Portfolio
  • 7.9.3 Financial Overview
  • 7.9.4 Key Developments
  • 7.9.5 SWOT Analysis
• 7.10 Copernicus Sp. z o.o.
  • 7.10.1 Company Overview
  • 7.10.2 Product Portfolio
  • 7.10.3 Financial Overview
  • 7.10.4 Key Developments
  • 7.10.5 SWOT Analysis

8.0 Chapter 8

• 8.1 Research Methodology
• 8.2 About Us
• 8.3 Disclaimer